A pre-filled syringe (PFS) is a single-dose disposable syringe which comes pre-filled with the substance to be injected. Pre-filled syringes constitute as one of the fastest growing segments of the injectable drug delivery ecosystem, with therapeutic applications ranging from vaccines, biologics, and biosimilars. PFS offer significant benefits over the traditional "vial and syringe" format, by increasing dosing accuracy, safety and convenience. In addition, pre-filled syringes also offer a variety of economic benefits to pharmaceutical companies including a reduction in drug overfill and waste, which increases the saleable yield of the API (Active Pharmaceutical Ingredient).

The “Pre-Filled Syringes Market: 2023 – 2033 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the pre-filled syringes ecosystem including technology, market drivers, challenges, investment potential, leading therapies, use cases, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for pre-filled syringe unit sales from 2023 through to 2033. The forecasts are further segmented for 4 horizontal submarkets, 9 drug classes, 5 regions and 15 leading countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

About SNS Research

SNS Research is a global market intelligence and consulting firm with a particular focus on the healthcare and pharmaceutical industries. Our core team is based in Pennsylvania, USA, with industry expert analysts working around the world to deliver a comprehensive global outlook on a range of topics in the healthcare sector. Trusted by our clients to meet their research needs, we serve organizations of all sizes. Our customers comprise of government agencies, drug manufacturers, biopharmaceutical companies, healthcare providers, educational institutions, international regulatory authorities, and investment firms.

Learn more at snsintel.com or contact us at [email protected].